Recent Updates
Recently added Catalysts
BVS Positive Sentiment Score: 65/100

Bioventus to Report Second Quarter of Fiscal Year 2025 Financial Results on August 6, 2025

Tuesday, July 29, 2025 2 min read
Key Takeaway: Bioventus Inc. has announced that it will report its financial results for the second quarter of fiscal year 2025 before market opening on August 6, 2025. A conference call will be held at 8:30 a.m. Eastern Time to discuss these results along with a business update. The company emphasizes its commitment to providing high-quality, evidence-based healing solutions, further highlighting its role in patient care and recovery.

Market Sentiment Analysis

POSITIVE FACTORS

  • Bioventus is poised to report its Q2 financial results, indicating ongoing business activity.
  • The company hosts a conference call to discuss results, showcasing transparency and investor engagement.
  • Bioventus continues to innovate with cost-effective, clinically proven products for active healing.

Full Press Release Details

DURHAM, N.C., July 29, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for the second quarter of fiscal year 2025 before the market opens on Wednesday, August 6, 2025. The Company’s management will host a conference call at 8:30 a.m. Eastern Time that same day to discuss the results and provide a business update.
To participate in the conference call, dial 1-800-715-9871 and refer either to the Bioventus Inc. Conference Call or the conference ID 1859022.
A live webcast of the call and accompanying materials will also be provided on the “Investor Relations” section of the Company's website at https://ir.bioventus.com/. The webcast will be archived at the same site and available for replay until August 5, 2026.
Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for Pain Treatments, Restorative Therapies and Surgical Solutions. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com and follow the Company on LinkedIn and Twitter. Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.
Investor and Media Inquiries:
Dave.Crawford@bioventus.com

Frequently Asked Questions

When will Bioventus report Q2 financial results?

Bioventus will report its second quarter financial results on August 6, 2025.

How can I participate in the Bioventus conference call?

To join the conference call, dial 1-800-715-9871 and reference the Bioventus ID 1859022.

Where can I find the Bioventus conference call webcast?

The webcast will be available in the 'Investor Relations' section of their website.

What innovations does Bioventus focus on?

Bioventus focuses on innovations for Pain Treatments, Restorative Therapies, and Surgical Solutions.

How long will the conference call webcast be available?

The webcast will be available for replay until August 5, 2026.

Tags: BVS Viatris Investor Conferences Healthcare Bioventus financial results fiscal year 2025 active healing
Last updated: Jul 29, 2025